CD44/CD24 and Aldehyde Dehydrogenase 1 in Estrogen Receptor-Positive Early Breast Cancer Treated With Tamoxifen: CD24 Positivity Is a Poor Prognosticator
Oncotarget - United States
doi 10.18632/oncotarget.23519
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 21, 2017
Authors
Publisher
Impact Journals, LLC